To clarify the effects of anti-osteoporosis drugs on preventing patients from areterial calcification. A multicentric study.

To clarify the effects of anti-osteoporosis drugs on preventing patients from areterial calcification. A multicentric study. - The effects of anti-osteoporosis drugs on prevention of areterial calcification

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016345

Enrollment

200

Registered

2015-02-10

Start date

2015-02-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with primary osteoporosis, compatible to Japanese criteron of primary osteoporosis a revised edition in 2012. 2. Patients with glucocorticod induced osteoporosis, compatible to guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese society of bone and mineral research, 2014 update.

Exclusion criteria

Exclusion criteria: 1. Metabolic bone diseases other than osteoporosis 2. Serious renal, hepatic, or cardiac disease 3. Patients who are considered appropriate for enrollement by the investigator.

Design outcomes

Primary

Measure	Time frame
Whether there are differences of calcification in aorta, abdominal aretery, or iliac artery between osteoporosis patients with treatmets and without treatment	—

Secondary

Measure	Time frame
1. Wheter there are correlation between severity of osteoporosis and severity of arterial calcification. 2. Wheter there are different effects of anti-osteoporotic drugs on prevention of arterial calcification	—

Countries

Japan

Contacts

Public ContactShinya Tanaka

Saitama medical university Orthopaedic surgery

tnk_sny@saitama-med.ac.jp+81-49-276-1238

Outcome results